A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Acadia:

ACADIA Pharmaceuticals (Nasdaq: ACAD) is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders including Schizophrenia and Parkinson's disease. ACADIA currently has five drug programs in clinical and preclinical development. Their three Phase II-stage clinical programs, for which we they have retained worldwide commercialization rights

ACP-103 for treatment-induced dysfunction in Parkinson's disease

ACP-103 as an adjunctive therapy for Schizophrenia

ACP-104 for treatment of Schizophrenia.

ACADIA also has clinical and preclinical development programs in the areas of neuropathic pain and glaucoma (in collaboration with Allergan, Inc.)

Drug Programs

ACP-103 as Adjunctive Therapy for Schizophrenia

ACADIA is developing ACP-103, a potent and selective 5-HT2Ainverse agonist, as an adjunctive therapy for schizophrenia. By adding ACP-103 in combination with currently-available antipsychotic drugs they believe that the optimal combination of dopamine receptor blockade and 5-HT2Ainverse agonism can be achieved, which may reduce the side effects associated with these drugs and expand their range of efficacy.

ACP-103 in Clinical Development

A proprietary small molecule discovered by ACADIA, is in development for treatment of the psychiatric and motoric dysfunction that frequently results from current Parkinson's disease therapies. ACP-103 is given orally and blocks the activity of the 5-HT2A receptor.

Neuropathic Pain

In collaboration with Allergan, ACADIA is developing a new class of small molecule drug candidates that they believe may represent a significant breakthrough in the treatment of neuropathic pain read more.


NIH Clinical Trials:

Hallucinations Psychoses Parkinson's Disease Colorectal Cancer MetastasesNIH Link

More on Acadia:

Home Page for Acadia

Key Statistics for Acadia

Basic Chart for Acadia

Analyst Opinion

Analysts Estimates

Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?




Copyright 2005 BIOTECH100.COM. All rights reserved.